Improvement in Motor and Walking Capacity during Multisegmental Transcutaneous Spinal Stimulation in Individuals with Incomplete Spinal Cord Injury
- PMID: 38674065
- PMCID: PMC11050444
- DOI: 10.3390/ijms25084480
Improvement in Motor and Walking Capacity during Multisegmental Transcutaneous Spinal Stimulation in Individuals with Incomplete Spinal Cord Injury
Abstract
Transcutaneous multisegmental spinal cord stimulation (tSCS) has shown superior efficacy in modulating spinal locomotor circuits compared to single-site stimulation in individuals with spinal cord injury (SCI). Building on these findings, we hypothesized that administering a single session of tSCS at multiple spinal segments may yield greater enhancements in muscle strength and gait function during stimulation compared to tSCS at only one or two segments. In our study, tSCS was applied at single segments (C5, L1, and Coc1), two segments (C5-L1, C5-Coc1, and L1-Coc1), or multisegments (C5-L1-Coc1) in a randomized order. We evaluated the 6-m walking test (6MWT) and maximum voluntary contraction (MVC) and assessed the Hmax/Mmax ratio during stimulation in ten individuals with incomplete motor SCI. Our findings indicate that multisegmental tSCS improved walking time and reduced spinal cord excitability, as measured by the Hmax/Mmax ratio, similar to some single or two-site tSCS interventions. However, only multisegmental tSCS resulted in increased tibialis anterior (TA) muscle strength. These results suggest that multisegmental tSCS holds promise for enhancing walking capacity, increasing muscle strength, and altering spinal cord excitability in individuals with incomplete SCI.
Keywords: gait; incomplete spinal cord injury; multiple segmental stimulation; muscle strength; spinal cord excitability; transcutaneous spinal cord stimulation.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Transcutaneous spinal cord stimulation on motor function in patients with spinal cord injury: A meta-analysis.NeuroRehabilitation. 2024;54(4):563-573. doi: 10.3233/NRE-240057. NeuroRehabilitation. 2024. PMID: 38943403 Review.
-
Neural Substrates of Transcutaneous Spinal Cord Stimulation: Neuromodulation across Multiple Segments of the Spinal Cord.J Clin Med. 2022 Jan 27;11(3):639. doi: 10.3390/jcm11030639. J Clin Med. 2022. PMID: 35160091 Free PMC article. Review.
-
Multisite Transcutaneous Spinal Stimulation for Walking and Autonomic Recovery in Motor-Incomplete Tetraplegia: A Single-Subject Design.Phys Ther. 2022 Jan 1;102(1):pzab228. doi: 10.1093/ptj/pzab228. Phys Ther. 2022. PMID: 35076067 Free PMC article.
-
Transcutaneous spinal cord stimulation of the cervical cord modulates lumbar networks.J Neurophysiol. 2020 Jan 1;123(1):158-166. doi: 10.1152/jn.00433.2019. Epub 2019 Nov 20. J Neurophysiol. 2020. PMID: 31747338
-
Augmentation of Voluntary Locomotor Activity by Transcutaneous Spinal Cord Stimulation in Motor-Incomplete Spinal Cord-Injured Individuals.Artif Organs. 2015 Oct;39(10):E176-86. doi: 10.1111/aor.12615. Epub 2015 Oct 6. Artif Organs. 2015. PMID: 26450344
References
-
- Pagliacci M.C., Celani M.G., Spizzichino L., Zampolini M., Aito S., Citterio A., Finali G., Loria D., Ricci S., Taricco M., et al. Gruppo Italiano Studio Epidemiologico Mielolesioni (GISEM) Group. spinal cord lesion management in Italy: A 2-year survey. Spinal Cord. 2003;41:620–628. doi: 10.1038/sj.sc.3101521. - DOI - PubMed
-
- Domingo A., Al-Yahya A.A., Asiri Y., Eng J.J., Tania Lam T., Spinal Cord Injury Rehabilitation Evidence Research Team A systematic review of the effects of pharmacological agents on walking function in people with spinal cord injury. J. Neurotrauma. 2012;29:865–879. doi: 10.1089/neu.2011.2052. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous